Sphingolipid Storage Diseases
USMLE Step 1 trap: Confuses the enzyme defects of Tay-Sachs and Niemann-Pick disease. Tay-Sachs lacks hexosaminidase A (accumulates GM2 ganglioside) and Niemann-Pick lacks sphingomyelinase (accumulates sphingomyelin).
Sphingolipid storage diseases are a cluster of lysosomal storage disorders where specific enzyme deficiencies cause toxic substrate buildup in cells. Each disease has a distinct enzyme, substrate, affected cell type, and clinical presentation — and USMLE Step 1 exploits every one of those differences. The exam tests this topic through direct recall (which enzyme is deficient?), clinical vignette matching (which patient has this presentation?), and inheritance pattern questions. Expect a vignette describing a child with neurodegeneration and cherry-red spot, or an adult with bone pain and hepatosplenomegaly, and be asked to identify the enzyme defect or the accumulated substrate.
The core difficulty is that these diseases blur together under pressure. They all involve lysosomal enzymes, they often share hepatosplenomegaly, and several affect the nervous system. Students routinely mix up Tay-Sachs and Niemann-Pick because both present with cherry-red spots and neurological decline in infants — but they have completely different enzyme defects and different substrates. Similarly, Krabbe and metachromatic leukodystrophy (MLD) both cause demyelination but accumulate different substrates via different enzymes. The exam counts on this confusion.
The other common trap is Fabry disease. Most students memorize the sphingolipidoses as 'all autosomal recessive' and get blindsided when a question flags X-linked inheritance. Fabry is the outlier: X-linked recessive, presents in males with peripheral neuropathy and angiokeratomas, and is caused by alpha-galactosidase A deficiency. USMLE Step 1 loves testing the exception to the rule, so Fabry's inheritance pattern is a guaranteed high-yield detail.
Common misconceptions
What the exam tests
- Given a vignette of an infant with a cherry-red macula, startle response to sound, and progressive neurodegeneration, identify whether the enzyme defect is hexosaminidase A (Tay-Sachs) or sphingomyelinase (Niemann-Pick) — and know how to distinguish the two based on additional clinical clues like hepatosplenomegaly (present in Niemann-Pick, absent in Tay-Sachs).
- Recognize Gaucher disease from its classic findings: bone pain, hepatosplenomegaly, pancytopenia, and lipid-laden macrophages with crinkled tissue-paper cytoplasm — and identify glucocerebrosidase (beta-glucosidase) as the deficient enzyme accumulating glucocerebroside.
- Identify Fabry disease as the only X-linked recessive sphingolipidosis, caused by alpha-galactosidase A deficiency, and recognize its presentation: peripheral neuropathy, angiokeratomas, corneal opacities, and renal/cardiac involvement in young males.
- Distinguish Krabbe disease from metachromatic leukodystrophy: Krabbe involves galactocerebrosidase deficiency accumulating galactocerebroside and presents with peripheral and central demyelination in infants, while MLD involves arylsulfatase A deficiency accumulating cerebroside sulfate and typically presents later with progressive gait and behavioral changes.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →